[Monoclonal antibodies against human brain tumors]

Tumor specific and various tumor associated antigens expressed on human brain tumor cells were reported from many laboratories, which have been identified by xeno, allo or autoantisera, and recently utilizing monoclonal antibodies produced by hybridoma technique. In this article, the results of reports are summarized comparing the studies with conventional antisera and monoclonal antibodies and clinical application of these monoclonal antibodies at present and in near future are described.